Showing results (1-10 of 209) with videos related to
Sort By:
Pageof 21
Gastroenterologie Clinique Et Biologique|July 30, 2008
[The patient with uncontrolled chronic hepatitis B]J-P Zarski, V LeroyJournal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 22, 2001
Dynamics of viral quasispecies during interferon therapy in non responder chronic hepatitis C patientsM A Thelu, M Baud, V Leroy, et al.Digestive Diseases and Sciences|December 1, 1996
Treatment of chronic hepatitis C by interferon for longer duration than six monthsT Poynard, V Leroy, P Mathurin, et al.Hepatology (Baltimore, Md.)|October 1, 1996
Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and durationT Poynard, V Leroy, M Cohard, et al.Clinical and Experimental Immunology|November 28, 2002
Simultaneous evaluation of lymphocyte subpopulations in the liver and in peripheral blood mononuclear cells of HCV-infected patients: relationship with histological lesionsM Pernollet, E Jouvin-Marche, V Leroy, et al.Journal of Medical Virology|January 25, 2007
IRES complexity before IFN-alpha treatment and evolution of the viral load at the early stage of treatment in peripheral blood mononuclear cells from chronic hepatitis C patientsM A Thélu, V Leroy, M Ramzan, et al.British Journal of Haematology|June 20, 1998
Prevalence and significance of anticardiolipin, anti-beta2 glycoprotein I and anti-prothrombin antibodies in chronic hepatitis CV Leroy, J Arvieux, M C Jacob, et al.Journal of Hepatology|April 29, 1998
Role of anti-interferon antibodies in breakthrough occurrence during alpha 2a and 2b therapy in patients with chronic hepatitis CV Leroy, M Baud, C de Traversay, et al.Journal of Viral Hepatitis|September 15, 2006
Longitudinal evaluation of a fibrosis index combining MMP-1 and PIIINP compared with MMP-9, TIMP-1 and hyaluronic acid in patients with chronic hepatitis C treated by interferon-alpha and ribavirinC Trocme, V Leroy, N Sturm, et al.Pageof 21